190 related articles for article (PubMed ID: 18937916)
1. Amelioration of beta654-thalassemia in mouse model with the knockdown of aberrantly spliced beta-globin mRNA.
Xie S; Li W; Ren Z; Zhang J; Guo X; Wang S; Huang S; Zeng F; Zeng YT
J Genet Genomics; 2008 Oct; 35(10):595-601. PubMed ID: 18937916
[TBL] [Abstract][Full Text] [Related]
2. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach.
Xie SY; Ren ZR; Zhang JZ; Guo XB; Wang QX; Wang S; Lin D; Gong XL; Li W; Huang SZ; Zeng F; Zeng YT
Hum Mol Genet; 2007 Nov; 16(21):2616-25. PubMed ID: 17716993
[TBL] [Abstract][Full Text] [Related]
3. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
[TBL] [Abstract][Full Text] [Related]
4. Reversal of aberrant splicing of beta-thalassemia allele by antisense RNA in vitro and in vivo.
Zeng Y; Gu X; Chen Y; Gong L; Ren Z; Huang S
Chin Med J (Engl); 1999 Feb; 112(2):107-11. PubMed ID: 11593572
[TBL] [Abstract][Full Text] [Related]
5. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
Malik P; Arumugam PI; Yee JK; Puthenveetil G
Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
[TBL] [Abstract][Full Text] [Related]
6. siRNA-mediated reduction of alpha-globin results in phenotypic improvements in beta-thalassemic cells.
Voon HP; Wardan H; Vadolas J
Haematologica; 2008 Aug; 93(8):1238-42. PubMed ID: 18556409
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of FV vectors with human α- or β-globin gene regulatory elements for the correction of β-thalassemia.
Morianos I; Siapati EK; Pongas G; Vassilopoulos G
Gene Ther; 2012 Mar; 19(3):303-11. PubMed ID: 21734726
[TBL] [Abstract][Full Text] [Related]
8. Engineered U7 snRNA mediates sustained splicing correction in erythroid cells from β-thalassemia/HbE patients.
Preedagasamzin S; Nualkaew T; Pongrujikorn T; Jinawath N; Kole R; Fucharoen S; Jearawiriyapaisarn N; Svasti S
Biochem Biophys Res Commun; 2018 Apr; 499(1):86-92. PubMed ID: 29550480
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of globin gene expression in different thalassaemia disorders: individual variation of β(E) pre-mRNA splicing determine disease severity.
Tubsuwan A; Munkongdee T; Jearawiriyapaisarn N; Boonchoy C; Winichagoon P; Fucharoen S; Svasti S
Br J Haematol; 2011 Sep; 154(5):635-43. PubMed ID: 21732929
[TBL] [Abstract][Full Text] [Related]
10. Role of alternatively spliced beta E-globin mRNA on clinical severity of beta-thalassemia/hemoglobin E disease.
Winichagoon P; Fucharoen S; Wilairat P; Chihara K; Fukumaki Y
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():241-5. PubMed ID: 8629114
[TBL] [Abstract][Full Text] [Related]
11. Correction of β654-thalassaemia mice using direct intravenous injection of siRNA and antisense RNA vectors.
Xie SY; Li W; Ren ZR; Huang SZ; Zeng F; Zeng YT
Int J Hematol; 2011 Mar; 93(3):301-310. PubMed ID: 21369857
[TBL] [Abstract][Full Text] [Related]
12. [Repair of the splicing defect of thalassemic allele beta IVS-2-654 C-->T in cultured human erythroid cells by antisense RNA].
Gu X; Gong L; Zhang W
Zhonghua Yi Xue Za Zhi; 1997 Nov; 77(11):815-8. PubMed ID: 9772473
[TBL] [Abstract][Full Text] [Related]
13. Repair of a splicing defect in erythroid cells from patients with beta-thalassemia/HbE disorder.
Suwanmanee T; Sierakowska H; Fucharoen S; Kole R
Mol Ther; 2002 Dec; 6(6):718-26. PubMed ID: 12498768
[TBL] [Abstract][Full Text] [Related]
14. Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β -Globin Gene with the IVSI-6 Thalassemia Mutation.
Breveglieri G; Mancini I; Bianchi N; Lampronti I; Salvatori F; Fabbri E; Zuccato C; Cosenza LC; Montagner G; Borgatti M; Altruda F; Fagoonee S; Carandina G; Rubini M; Aiello V; Breda L; Rivella S; Gambari R; Finotti A
Biomed Res Int; 2015; 2015():687635. PubMed ID: 26097845
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Mono- and Bi-Functional GLOBE-Based Vectors for Therapy of β-Thalassemia by
Koniali L; Flouri C; Kostopoulou MI; Papaioannou NY; Papasavva PL; Naiisseh B; Stephanou C; Demetriadou A; Sitarou M; Christou S; Antoniou MN; Kleanthous M; Patsali P; Lederer CW
Cells; 2023 Dec; 12(24):. PubMed ID: 38132168
[TBL] [Abstract][Full Text] [Related]
16. Reversal of aberrant splicing of beta-thalassaemia allele (IVS-2-654 C-->T) by antisense RNA expression vector in cultured human erythroid cells.
Gong L; Gu XF; Chen YD; Ren ZR; Huang SZ; Zeng YT
Br J Haematol; 2000 Oct; 111(1):351-8. PubMed ID: 11091224
[TBL] [Abstract][Full Text] [Related]
17. Relationship between AHSP gene expression, β/α globin mRNA ratio, and clinical severity of the β-thalassemia patients.
Ranjbaran R; Okhovat MA; Mobarhanfard A; Aboualizadeh F; Abbasi M; Moezzi L; Golafshan HA; Behzad-Behbahani A; Bagheri M; Sharifzadeh S
Ann Clin Lab Sci; 2014; 44(2):189-93. PubMed ID: 24795058
[TBL] [Abstract][Full Text] [Related]
18. Restoration of correct β
Nualkaew T; Jearawiriyapaisarn N; Hongeng S; Fucharoen S; Kole R; Svasti S
Sci Rep; 2019 May; 9(1):7672. PubMed ID: 31113996
[TBL] [Abstract][Full Text] [Related]
19. Short-hairpin RNA against aberrant
Patsali P; Papasavva P; Stephanou C; Christou S; Sitarou M; Antoniou MN; Lederer CW; Kleanthous M
Haematologica; 2018 Sep; 103(9):e419-e423. PubMed ID: 29700171
[No Abstract] [Full Text] [Related]
20. A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia.
Jamsai D; Zaibak F; Vadolas J; Voullaire L; Fowler KJ; Gazeas S; Peters H; Fucharoen S; Williamson R; Ioannou PA
Genomics; 2006 Sep; 88(3):309-15. PubMed ID: 16631345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
